Remote Exercise Testing in Patients With Pulmonary Hypertension
NCT ID: NCT05299463
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-06-09
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with pulmonary hypertension develop high blood pressure within the lungs, leading to a limitation in the amount of exercise they are able to perform. At diagnosis and follow-up patients routinely perform short exercise tests which are performed under supervision in the clinic or hospital. The results from these are compared over time and are used to assess how stable patients are. Currently, patients are required to travel to hospital to perform such a test and thus telephone or video appointments do not include this information. This study aims to investigate a range of exercise tests to assess whether they are valid in pulmonary hypertension (whether the results are comparable to the results from the current exercise test performed in hospital, the six-minute walk test) and whether it is feasible for patients to to perform these tests at home.
The investigators aim to investigate four different home exercise tests, including a sit-to-stand test, a timed up and go test, a six-minute walk test and a step test. The investigators will ask patients to perform these tests in a hospital environment and at home on two occasions. The results of these will be compared to see how they change over time and will be compared to other results obtained during standard care. Additionally, patients will be asked a questionnaire to assess their views on the four tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
NCT01275703
Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia
NCT03092622
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely
NCT04903704
CPET in Evaluation of PH in COPD Patients
NCT04035148
Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension
NCT04254289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Exercise Testing
* Tele-Six-minute walk test (T6MWT)
* 1 Minute Sit-to-stand test (STS)
* 2-minute symptom-limited Step test (ST)
* 3-metre Timed up and go test (TUG).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Testing
* Tele-Six-minute walk test (T6MWT)
* 1 Minute Sit-to-stand test (STS)
* 2-minute symptom-limited Step test (ST)
* 3-metre Timed up and go test (TUG).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with pulmonary hypertension from any ERS/ESC group
* Able to give informed consent
Exclusion Criteria
* Restricted so as unable to perform a standard 6MWT, either due to mobility or symptoms
* Patients feel they would be unable to perform any of the 4 study tests when at home
* Concerns about the patient's safety of performing home-based exercise tests (as decided by the consenting clinician and/or the patient)
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Golden Jubilee National Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scottish Pulmonary Vascular Unit
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Val Irvine
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Val Irvine
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
293065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.